Flu Vaccination

FLUAD Quad & Flucelvax Quad

We’re all susceptible to flu and know how important that flu shot is, to keep us doing things we need or love to do.

There are now more advanced influenza vaccines that can offer greater protection to the standard flu vaccines that have been available. Introducing new Flucelvax® Quad for adults and children and FLUAD® Quad, specifically designed for 65 years and over. Both lower the chances of contracting flu or needing medical attention for flu-related complications compared to the standard flu vaccine.

Flucelvax Quad – For people aged 6 months and over
Flucelvax Quad is available in New Zealand for the first time this flu season, for people aged 6 months and over.

Why should I choose Flucelvax Quad?

  • Flucelvax Quad reduces your chances of catching the flu or needing medical attention for flurelated complications compared to the standard flu vaccine.
  • Flucelvax Quad is designed to be an exact match to the flu strains that are circulating this year.
  • Flucelvax Quad has been shown to be up to 19% more effective than standard influenza vaccines at protecting you from the flu.

 

 

Fluad Quad – For people aged 65 years old or over
For those 65 years old or over, influenza immunisation is very important, as the risks associated with the illness increase as you age. The risk of hospitalisation, long-term disability, loss of independence and even death are all greater if you get the flu compared to a younger, healthy adult. Compounding these issues, the effectiveness of the flu vaccine decreases as you get older and your immune system becomes weaker.

That’s why FLUAD Quad has been designed to offer greater protection against the flu in people aged 65 years and over compared with standard influenza vaccines.

Benefits of FLUAD Quad vaccine

  • Less chance at contracting the flu compared with the standard vaccine.*
  • Lower risk of needing to see a doctor, ED or be hospitalised with flu related complications compared with the standard vaccine.*^
  • Longer protection against the flu. Antibody levels are higher at 12 months post vaccination compared with the standard vaccine.*

 

Ask your health professional about advanced flu vaccines, FLUAD Quad and Flucelvax Quad.

 

Please note Fluad Quad and Flucelvax Quad are not funded. A charge will apply.

Related Topics

Join New Zealand’s trusted health & wellbeing community

Access to New Zealand's largest resource of health and wellness information, with regular updates sent to your inbox. PLUS, be in to win great giveaways.
Join Us

Consumer Infomation

† May not predict a clinical effect * FLUAD trivalent formulation compared with standard trivalent dose influenza vaccine. ^ Observational studies.

Flucelvax® Quad is an inactivated influenza vaccine, prepared in cell cultures. Flucelvax® Quad is an unfunded Prescription Medicine, charges may apply. Flucelvax® Quad is for the prevention of influenza in adults and children aged 6 months of age and older. Each dose contains 60 micrograms/0.5 mL of surface haemagglutinin and neuraminidase from four influenza virus strains, type A and B. Flucelvax® Quad has risks and benefits. Ask your healthcare professional if Flucelvax® Quad is right for you. Side effects include injection site reactions such as pain, redness, swelling or formation of hard lumps and bruising; muscle aches or joint pain; flu-like symptoms such as headache, fatigue, fever, chills, cough, sore throat, runny or blocked nose; nausea, vomiting, diarrhoea and loss of appetite. Serious side effects include Guillain- Barré syndrome (feeling weak, numbness and tingling in your limbs). Tell your healthcare professional if you have ever had an allergic reaction to any vaccine or to any of the listed ingredients for Flucelvax® Quad. If you have side effects after being given Flucelvax® Quad, talk to your healthcare professional. Additional product consumer information on Flucelvax® Quad is available from www.medsafe.govt.nz; Seqirus, Auckland on 0800 502 757. Flucelvax® Quad is a registered trademark of Seqirus UK Ltd and its affiliates. Seqirus, Auckland 10/23.

FLUAD® Quad is an inactivated influenza vaccine, with an MF59® Adjuvant. FLUAD® Quad is an unfunded Prescription Medicine, a charge may apply. FLUAD® Quad is for active immunisation against influenza for people aged 65 years and older. Each dose contains 60 micrograms/0.5 mL of surface antigens from four influenza virus strains. FLUAD® Quad has risks and benefits. Ask your healthcare professional if FLUAD® Quad is right for you. Common side effects; injection site reactions e.g. pain, swelling, and redness warmth, burning or stinging, bruising. Fatigue, headache, aching muscles or joints, diarrhoea, chills, nausea, loss of appetite, vomiting fever. Very rarely, Guillain-Barré syndrome (feeling weak, numbness and tingling in your limbs). Tell your healthcare professional if you have ever had an allergic reaction to any vaccine, egg or to any of the listed ingredients for FLUAD® Quad. If you experience side effects after being given FLUAD® Quad, talk to your healthcare professional. Additional product consumer information on FLUAD® Quad can be found at www.medsafe.govt.nz, CSL Seqirus, Auckland or 0800 502 757. FLUAD® and FLUAD® Quad are registered trademarks of Seqirus UK Ltd. 10/23 NZ-FLU-24-0014. TAPS NP20568 NZ-FLU-24-0014